Episode
9

Building (and Funding) Neurotech Companies

July 25, 2021
Back to all

1:08 | Meeting Heros

2:18 | The Ian Burkhart Foundation

5:55 | Vasilis Marmarelis, PhD

7:35 | BCI All-Stars

7:48 | Winfried Denk, PhD

8:02 | Company Origins: NeuroPace, Blackrock, and Nēsos

8:48 | NeuroPace

9:08 | Ventritex

9:36 | Robert Fischell, PhD

9:58 | Meet the Fischell’s

10:11 | Irving S. Cooper, MD

13:04 | Epilepsy Monitoring Unit at Columbia

14:01 | The Utah Array

14:21 | Richard A. Normann, MD, PhD

15:05 | John Donoghue, PhD

17:07 | Cyberkinetics

16:28 | Kleiner Perkins

20:05 | Letos

20:09 | Cyberonics

20:13 | Northstar Neuroscience

21:09 | Nevro

22:53 | Effect of High-Frequency Stimulation on Pain Transmission

23:24 | Jason M. Cuellar, MD, PhD

25:28 | Now vs Then, a Decade of Neurotech Entrepreneurship

25:29 | Nēsos (formally Vorso Corp)

26:26 | Inspire Sleep Apnea Implant

26:55 | Neuroimmune Interactions

27:01 | Wearable Nervous Stimulation Technology

27:11 | Landmark Clinical Trial

28:40 | Florian Solzbacher, PhD

32:52 | Cochlear Implant

43:47 | Epilepsy Seizures Recording

47:41 | Argus II Retinal Implant

51:03 | Jennifer Collinger, PhD

51:14 | Nathan Copeland

54:31 | Medicare Coverage of Innovative Technology

54:44 | Synchron’s Breakthrough Device Designation

57:12 | Robert Greenberg, MD

57:16 | Alfred Mann Foundation

1:00:15 | Natus Neuro

1:04:50 | Investor Backing in Neurotech

1:10:55 | Brian Johnson’s Kernel

1:13:24 | Moderna Therapeutics

1:20:44 | BCI Future Is Underway

1:24:30 | RNS therapy for addictive behaviors

1:24:44 | Preclinical Research on Addictive Behavior

1:27:20 | Huma

Have any questions or want

to learn more?

Reach out to our team, and we'll be in touch.